Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
hormone
Research
Veru touts novel breast cancer treatment strategy
Veru aims to launch a phase 3 study of its androgen receptor agonist enobosarm in heavily pretreated ER-positive/HER2-negative breast cancer.
Angus Liu
Jan 21, 2021 7:31am
BridgeBio's en route to proving out its 'Moneyball' model: CEO
Sep 29, 2020 7:00am
Spruce scores phase 2a win for rare disease drug, preps for 2020
Sep 19, 2019 8:00am
A new approach to resistant prostate cancer
Aug 29, 2019 9:00am
Could the 'hunger hormone' boost memory?
Jul 10, 2019 10:20am
New insight into melatonin could lead to better sleep drugs
Apr 25, 2019 12:58pm